Role of Uttarbasti in the Management of Mutra Marga Sankoch (Urethral Stricture) - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Role of Uttarbasti in the Management of Mutra Marga Sankoch (Urethral Stricture)

This study has been completed.

Study NCT00535717. Last updated on September 25, 2007. Information provided by Maharashtra University of Health Sciences

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields

Brief Title ^†

Role of Uttarbasti in the Management of Mutra Marga Sankoch (Urethral Stricture)

Official Title ^†

Role of Uttarbasti in the Management of Mutra Marga Sankoch (Urethral Stricture)

Brief Summary

Uttarbasti is per urethral administration of medicated oil which has been recommended by Sushrut for urinary track disorders.

As far as conventional surgery is concerned urethral stricture still remains a challenge due to post procedural high recurrences and complications

Uttarbasti being almost non invasive, with minimum recurrences and most economical, easy to practice OPD procedure, can be the treatment of choice in the management of urethral stricture.

Detailed Description

Study Phase

Phase II

Study Type ^†

Interventional

Study Design ^†

Treatment, Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study

Primary Outcome Measure ^†

Secondary Outcome Measure ^†

Condition ^†

Urethral Stricture

Intervention ^†

Procedure: uttarbasti (per urethral administration of medicated oil )

MEDLINE PMIDs

Links

Recruitment Information Fields

Recruitment Status ^†

Completed

Enrollment ^†

Start Date ^†

Completion Date

Eligibility Criteria ^†

Inclusion Criteria:

K/C/O Urethral Stricture of either sex and from all age groups.

Exclusion Criteria:

With acute UTI.
DM.
Neoplasms of lower urinary tract
BEP.
With impacted calculus in urethra and bladder neck.

Gender

Both

Ages

Accepts Healthy Volunteers

Yes

Contacts ^††

Location Countries ^†

Administrative Information Fields

NCT ID ^†

NCT00535717

Organization ID

MUHS RIA

Secondary IDs ^††

Study Sponsor ^†

Maharashtra University of Health Sciences

Collaborators ^††

Investigators ^†

Principal Investigator:

Rajendra H Amilkanthwar, M.D.(Ayu.)

Maharashtra university of health sciences, Nashik (INDIA)

Information Provided By

Maharashtra University of Health Sciences

Verification Date

September 2007

First Received Date ^†

September 25, 2007

Last Updated Date

September 25, 2007

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.